SCHEMBL28069862

SCHEMBL28069862

Cc1ccc(=O)n(Cc2ccccc2)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TSHR P16473 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ATM Q13315 1/20 0.46
POLB P06746 2/20 0.45
MAPT P10636 2/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
HSD17B10 Q99714 1/20 0.44
FABP4 P15090 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
FOLH1 Q04609 1/20 0.43
USP2 O75604 1/20 0.42
THRB P10828 1/20 0.42
NR4A1 P22736 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27951530 0.84 MAPT (0.48) LMNASMN1; SMN2TSHRMEN1KMT2A
SCHEMBL12502625 0.84 TSHR (0.54) LMNASMN1; SMN2TSHRMEN1KMT2A
SCHEMBL28829407 0.78 GSK3A (0.41) NOTUMLMNASMN1; SMN2TSHRMEN1
SCHEMBL3001518 0.75 GSK3B (0.52) NOTUMLMNASMN1; SMN2TSHRALDH1A1
SCHEMBL12502788 0.72 TSHR (0.51) LMNASMN1; SMN2TSHRMEN1KMT2A
SCHEMBL182646 0.72 FOLH1 (0.49) NOTUMLMNASMN1; SMN2TSHRMEN1
SCHEMBL28841921 0.72 CCR2 (0.49) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL289221 0.71 CAPN1 (0.54) NOTUMLMNASMN1; SMN2TSHRMEN1
SCHEMBL23660840 0.70 KMT2A (0.51) NOTUMLMNASMN1; SMN2TSHRMEN1
SCHEMBL17625299 0.70 FOLH1 (0.62) LMNASMN1; SMN2MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103608346-B As the 7-naphthyridine derivatives of hypoxia inducible factor (HIF) hydroxylase inhibitors 菲布罗根有限公司 2016-06-15 CN disclosed